![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BioElectronics Announces Distribution Agreement With PD-Rx
BioElectronics Announces Distribution Agreement With PD-Rx
BioElectronics, a developer of advanced, disposable, therapeutic medical devices, announced that it has entered into an agreement with PD-Rx for PD-Rx to distribute ActiPatch Therapy to physicians and healthcare providers that participate in the PD-Rx programs.
ActiPatch Therapy is a dermal patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for a few dollars a day. The patch delivery system and the company's patented technology provides an inexpensive, self-administered equivalent of the operator-administered pulsed electromagnetic energy therapy used extensively worldwide to reduce swelling, relieve pain and enhance the healing of post-surgical incisions, chronic wounds (bedsores) and orthopedic conditions.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct